James Arthur Bristol's Net Worth
$8.61 Million
Who is James Arthur Bristol?
James Arthur Bristol has an estimated net worth of $8.61 Million. This is based on reported shares across multiple companies, which include Erasca, Inc., Deciphera Pharmaceuticals, Inc., and Eterna Therapeutics Inc..
SEC CIK
James Arthur Bristol's CIK is 0001715153
Past Insider Trading and Trends
2019 was James Arthur Bristol's most active year for acquiring shares with 8 total transactions. James Arthur Bristol's most active month to acquire stocks was the month of May. 2020 was James Arthur Bristol's most active year for disposing of shares, totalling 25 transactions. James Arthur Bristol's most active month to dispose stocks was the month of December. 2022 saw James Arthur Bristol paying a total of $132,755.40 for 88,070 shares, this is the most they've acquired in one year. In 2019 James Arthur Bristol cashed out on 150,000 shares for a total of $2,826,974.16, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Erasca, Inc. (ERAS) Snapshot price: $1.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
∞
| 20K |
$4.14 | $82,800.00 | 20K |
Dec 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Deciphera Pharmaceuticals, Inc. (DCPH) Snapshot price: $14.005
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
$25.03 | -$295,043.74 |
0
|
Scheduled
|
Apr 19 - Apr 20
| ||
Form 4
|
—
|
0
|
$23.90 | -$586,345.60 |
0
|
Scheduled
|
Apr 12
| ||
Form 4
|
—
|
0
|
$27.12 | -$324,389.44 |
0
|
Scheduled
|
Jan 15
| ||
Form 4
|
—
|
0
|
$27.73 | -$1,216,576.08 |
0
|
Scheduled
|
Oct 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
$28.44 | -$1,250,141.06 |
0
|
Scheduled
|
Jul 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
$22.86 | -$987,345.46 |
0
|
Scheduled
|
Apr 9
| ||
Form 4
|
—
|
0
|
$29.78 | -$1,313,168.69 |
0
|
Scheduled
|
Jan 2 - Jan 3
| ||
Form 4
|
—
|
0
|
$23.48 | -$1,079,572.50 |
0
|
Scheduled
|
Nov 1
| ||
Form 4
|
—
|
0
|
$20.93 | -$952,115.35 |
0
|
Scheduled
|
Aug 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
$14.97 | -$493,756.73 |
0
|
Scheduled
|
Feb 14 - Feb 15
| ||
Form 4
|
—
|
0
|
$14.95 | -$91,980.02 |
0
|
Scheduled
|
Feb 12 - Feb 13
| ||
Form 4
|
—
|
0
|
$14.96 | -$67,799.57 |
0
|
Scheduled
|
Feb 5
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Eterna Therapeutics Inc. (ERNA) Snapshot price: $1.595
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||